Senesco Logo
Home About Us News + Media Our Technology Commercialization Investor Relations Contact Us
   
  Senesco's platform technology is based upon the identification and characterization of specific genes that regulate cell death in plants (senescence) and humans (apoptosis). Our mission is to apply our technology to improve commercial agriculture and to develop treatments for medical conditions in humans.
 
6.9.2009
SENESCO TECHNOLOGIES INC. ANNOUNCES THE APPOINTMENT OF DR. HARLAN W. WAKSAL, M.D. AS CHAIRMAN OF THE BOARD OF DIRECTORS AND THE ADDITION OF MR. WARREN J. ISABELLE, CFA TO ITS BOARD OF DIRECTORS
 
5.27.2009
Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy
 
5.26.2009
Senesco Announces H1N1 Influenza Survival Test Results in Mice
 
  Disclaimer